Business
Press Release Mar 24 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 24, 2023, titled "Zydus receives Final Approval from the USFDA for Lubiprostone Capsules, 8 mcg and 24 mcg".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 24, 2023, titled \"Zydus receives Final Approval from the USFDA for Lubiprostone Capsules, 8 mcg and 24 mcg\". View Attachment","length":353,"tagName":"div"}]